← Back to Search

Stress Impact for Rosacea

N/A
Recruiting
Led By Kristen Metzler-Wilson, PT, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate (during the single-day study). this study consists of a one-day protocol, during which this outcome is measured.
Awards & highlights

Study Summary

This trial seeks to understand how stress can trigger rosacea symptoms to inform treatments for the 16 million Americans it affects.

Who is the study for?
This trial is for healthy males and females with mild to moderate rosacea, who are not pregnant or breastfeeding. Participants should not have any major health issues like heart or neurological disorders, no recent drug/alcohol abuse, no allergies to protocol drugs, non-smokers, and a BMI under 35.Check my eligibility
What is being tested?
The study investigates how stressors affecting the 'fight or flight' nervous system contribute to rosacea symptoms. It aims to improve understanding of this relationship in order to develop better treatments for those suffering from rosacea.See study design
What are the potential side effects?
Since the trial involves studying the effects of systemic and local stressors on individuals with rosacea rather than testing new medications, specific side effects are not listed but may include temporary increased redness or inflammation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate (during the single-day study). this study consists of a one-day protocol, during which this outcome is measured.
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediate (during the single-day study). this study consists of a one-day protocol, during which this outcome is measured. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Skin blood flow
Skin sympathetic nerve activity

Trial Design

1Treatment groups
Experimental Treatment
Group I: Autonomic responses to stressorsExperimental Treatment1 Intervention
Protocol 1: mental math and handgrip exercise. Protocol 2: systemic stressors and end-organ receptor stimulation. Protocol 3: local heating.

Find a Location

Who is running the clinical trial?

Marian UniversityOTHER
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
982,772 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
484 Previous Clinical Trials
1,086,797 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are geriatric individuals aged 85 years or above allowed to participate in this experiment?

"According to the eligibility guidelines for this clinical trial, eligible participants must be between 18 and 45 years of age."

Answered by AI

Who is eligible to partake in this research project?

"In order to meet the criteria of this research trial, patients must have rosacea and be between 18-45 years old. At present, 210 individuals are needed for the experiment."

Answered by AI

Is recruitment still underway for this clinical experiment?

"Affirmative, according to the clinicaltrials.gov platform this study is actively seeking participants. The trial was first advertised on May 24th 2019 and last amended on March 29th 2023 with a recruitment goal of 210 patients from one site."

Answered by AI

How many test subjects have been recruited for this experiment?

"Affirmative. Clinicaltrials.gov contains information that shows this research is currently recruiting volunteers, with the initial posting being made on May 24th 2019 and an update occurring recently on March 29th 2023. A total of 210 people are required to participate in studies held at one location."

Answered by AI
~10 spots leftby Aug 2024